Skip to main content

Abstract CT228: Talazoparib (Tala) in patients (pts) with solid tumors with ATM alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Publication ,  Conference
Dib, EG; Rothe, M; Mangat, PK; Garrett-Mayer, E; Bivins, D; Gitau, M; Ganti, AK; Winer, A; Suhag, V; Outlaw, D; Hall, MJ; Alese, OB; Yan, F ...
Published in: Cancer Research
April 25, 2025

Duke Scholars

Published In

Cancer Research

DOI

EISSN

1538-7445

ISSN

0008-5472

Publication Date

April 25, 2025

Volume

85

Issue

8_Supplement_2

Start / End Page

CT228 / CT228

Publisher

American Association for Cancer Research (AACR)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dib, E. G., Rothe, M., Mangat, P. K., Garrett-Mayer, E., Bivins, D., Gitau, M., … Schilsky, R. L. (2025). Abstract CT228: Talazoparib (Tala) in patients (pts) with solid tumors with ATM alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. In Cancer Research (Vol. 85, pp. CT228–CT228). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2025-ct228
Dib, Elie G., Michael Rothe, Pam K. Mangat, Elizabeth Garrett-Mayer, Dustin Bivins, Mark Gitau, Apar K. Ganti, et al. “Abstract CT228: Talazoparib (Tala) in patients (pts) with solid tumors with ATM alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.” In Cancer Research, 85:CT228–CT228. American Association for Cancer Research (AACR), 2025. https://doi.org/10.1158/1538-7445.am2025-ct228.
Dib EG, Rothe M, Mangat PK, Garrett-Mayer E, Bivins D, Gitau M, et al. Abstract CT228: Talazoparib (Tala) in patients (pts) with solid tumors with ATM alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. In: Cancer Research. American Association for Cancer Research (AACR); 2025. p. CT228–CT228.
Dib, Elie G., et al. “Abstract CT228: Talazoparib (Tala) in patients (pts) with solid tumors with ATM alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.” Cancer Research, vol. 85, no. 8_Supplement_2, American Association for Cancer Research (AACR), 2025, pp. CT228–CT228. Crossref, doi:10.1158/1538-7445.am2025-ct228.
Dib EG, Rothe M, Mangat PK, Garrett-Mayer E, Bivins D, Gitau M, Ganti AK, Winer A, Suhag V, Outlaw D, Hall MJ, Alese OB, Nazemzadeh R, Pisick E, Yan F, Hafez N, Calfa CJ, Leonhardt L, DeRemer D, Gregory A, Hinshaw DC, Grantham GN, Halabi S, Schilsky RL. Abstract CT228: Talazoparib (Tala) in patients (pts) with solid tumors with ATM alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. Cancer Research. American Association for Cancer Research (AACR); 2025. p. CT228–CT228.

Published In

Cancer Research

DOI

EISSN

1538-7445

ISSN

0008-5472

Publication Date

April 25, 2025

Volume

85

Issue

8_Supplement_2

Start / End Page

CT228 / CT228

Publisher

American Association for Cancer Research (AACR)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis